Previous clinical and experimental studies showed that serum FGF23 levels were significantly associated with LVH in patients with CKD (8–12), whereas other previous clinical and experimental studies revealed that there was no significant relationship between FGF23 and LVH (13–15). The gene discussed is FGF23; the disease is chronic kidney disease.